Search

Your search keyword '"M S Stack"' showing total 39 results

Search Constraints

Start Over You searched for: Author "M S Stack" Remove constraint Author: "M S Stack"
39 results on '"M S Stack"'

Search Results

1. Aged Breast Extracellular Matrix Drives Mammary Epithelial Cells to an Invasive and Cancer‐Like Phenotype

2. Epithelial ovarian cancer experimental models

3. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis

4. Reciprocal interactions between adhesion receptor signaling and MMP regulation

5. Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment

6. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation

7. Human Mast Cell Tryptase Fibrinogenolysis: Kinetics, Anticoagulation Mechanism, and Cell Adhesion Disruption

8. Metastatic Dissemination of Human Ovarian Epithelial Carcinoma Is Promoted by α2β1-Integrin-Mediated Interaction with Type I Collagen

9. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin

10. Fluorescence Quenching Studies of Matrix Metalloproteinases (MMPs): Evidence for Structural Rearrangement of the proMMP-2/TIMP-2 Complex upon Mercurial Activation

11. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells

12. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase)

13. The Effect of Substituted Laminin A Chain-Derived Peptides on the Conformation and Activation Kinetics of Plasminogen

14. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator

15. Masticatory biomechanics and masseter fiber-type plasticity

16. Thiol-based inhibitors of mammalian collagenase. Substituted amide and peptide derivatives of the leucine analogue, 2-[(R,S)-mercaptomethyl]-4-methylpentanoic acid

17. Analysis of matrix degradation

18. Isoform-specific differences in the size of desmosomal cadherin/catenin complexes

19. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells

20. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association

21. Proteolytic modification of laminins: functional consequences

22. Membrane associated matrix metalloproteinases in metastasis

23. Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment

24. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation

25. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin

26. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion

27. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI

28. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells

29. Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells

30. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin

31. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells

32. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase)

33. Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain

34. Effect of desialylation on the biological properties of human plasminogen

35. Thiol-based inhibitors of mammalian collagenase. Substituted amide and peptide derivatives of the leucine analogue, 2-[(R,S)-mercaptomethyl]-4-methylpentanoic acid

37. Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide

38. Inhibition of purified collagenase from alkali-burned rabbit corneas

39. Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide

Catalog

Books, media, physical & digital resources